Evaluation of: Waldmann TA, Conlon KC, Stewart DM et al. Phase 1 trial of IL-15 trans presentation blockade using humanized Mik-β-1 mAb in patients with T-cell large granular lymphocytic leukemia.
Expert Rev Clin Immunol. 2013;9(5):405-408. The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback